[The ideal dosage form for clinical study. Bosentan in pediatric patients].
Heinrich-Heine-Universität Düsseldorf, Düsseldorf.
Sergej
S
Ramusovic
Stephanie
S
Läer
Jörg
J
Breitkreutz
D000375:Aging / Q000502:physiology; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077300:Bosentan; D002626:Chemistry, Pharmaceutical; D002648:Child; D004304:Dosage Forms; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004304:Dosage Forms; D013449:Sulfonamides; D000077300:Bosentan